Traina et al. demonstrated that HER2 overexpression was significantly correlated with negative hormone receptor (HR) status, positive nodal status and G3 tumor grade based on data from 1355 Italian breast cancer patients [20]. This evidence concerns the gene NR4A1 and neoplasm.